Study Background: The Cardiovascular Burden of Air Pollution
Particulate matter with diameters ≤2.5 micrometers (PM2.5) has long been recognized as an environmental risk factor for cardiovascular disease (CVD), a leading cause of morbidity and mortality worldwide. However, emerging evidence suggests that not all PM2.5 components exert equal harm. Differentiating the cardiovascular risks attributable to chemical constituents within PM2.5 could refine regulatory policies and interventions to reduce the global burden of CVD. China, with its substantial population and varying air pollution profiles, provides a crucial setting to advance understanding about how specific PM2.5 components influence incident cardiovascular disease.
Study Design and Methods
The China Kadoorie Biobank (CKB) cohort study enrolled 487,037 adults free of CVD and cancer at baseline, recruited across diverse communities in China. Individual-level exposure to PM2.5 and six major chemical components — black carbon (BC), organic matter, chloride (Cl-), nitrate (NO3-), sulfate (SO42-), and ammonium (NH4+) — was estimated using a spatially resolved model at a fine 1 × 1 km resolution. Exposure was treated as a 3-year moving average preceding CVD events, allowing assessment of long-term pollutant exposure.
A time-varying Cox proportional hazards model was the primary analytic method to estimate hazard ratios (HRs) for incident total CVD and specific subtypes (ischemic heart disease, ischemic stroke, hemorrhagic stroke, and other cerebrovascular diseases) associated with interquartile range increases in individual PM2.5 components. Additionally, substitution models examined the cardiovascular risks associated with compositional shifts within PM2.5 while keeping the total mass constant, thus evaluating the differential toxicity of components relative to one another.
Key Findings
Over a median follow-up of 15.1 years, 196,224 CVD cases were documented, including ischemic heart disease (72,747 cases), ischemic stroke (74,594), hemorrhagic stroke (17,553), and other cerebrovascular diseases (54,306).
Long-term exposure to PM2.5 components was robustly associated with elevated CVD risk. Hazard ratios per interquartile range (IQR) increase in component concentration indicated that:
– Black Carbon (BC): HR 1.15 (95% CI 1.13–1.17)
– Organic Matter: HR 1.17 (95% CI 1.15–1.18)
– Chloride (Cl-): HR 1.28 (95% CI 1.25–1.32)
– Nitrate (NO3-): HR 1.29 (95% CI 1.24–1.33)
– Sulfate (SO42-): HR 1.23 (95% CI 1.20–1.25)
Notably, chloride, sulfate, and black carbon showed particularly strong associations with ischemic stroke and ischemic heart disease risk.
Substitution analyses underlined the importance of composition: replacing 1% of any other PM2.5 component with chloride corresponded to a 3%–8% higher total CVD risk, substitutions with black carbon were linked to a 1%–8% higher ischemic stroke risk, and sulfate substitutions were associated with a 2%–5% increase in ischemic heart disease risk.
These findings underscore not only the overall detrimental cardiovascular effects of PM2.5 mass but also the differential toxicity related to specific chemical profiles.
Expert Commentary and Biological Plausibility
The study contributes compelling evidence that the chemical composition of PM2.5 critically modulates cardiovascular risk. Black carbon, a marker of combustion-derived particles, is known to promote oxidative stress and systemic inflammation, mechanisms integral to atherogenesis and thrombosis. Sulfate and nitrate, secondary inorganic aerosols, may contribute to endothelial dysfunction and vascular inflammation. Chloride’s association is less well characterized biologically but may involve interactions with other toxic elements or pro-inflammatory pathways.
This study’s strengths include the large sample size, extensive follow-up, high spatial resolution exposure assessment, and use of sophisticated statistical modeling. Nonetheless, limitations warrant consideration: residual confounding due to unmeasured factors, potential exposure misclassification from geocoding, and inability to fully disentangle sources of PM2.5 components remain challenges.
Moreover, generalizability may be limited to populations with similar air pollution profiles. Still, the consistency and magnitude of associations reinforce the causality argument and align with prior mechanistic and epidemiological literature.
Conclusion
This landmark cohort study demonstrates that long-term exposure to specific PM2.5 components—particularly chloride, black carbon, and sulfate—is linked to elevated incident cardiovascular disease risk in a large Chinese population. The findings emphasize that not all particles are created equal: targeted air quality control strategies focusing on the most harmful chemical components could yield substantial cardiovascular health benefits. Future research should explore intervention efficacy and detailed mechanistic pathways to inform policy and clinical guidance.
Funding and Trial Registration
This study was conducted under the auspices of the China Kadoorie Biobank Collaborative Group. Detailed funding sources and clinical trial registrations were not specified in the report.
References
Shi H, Cheng S, Sun D, et al. Associations Between PM2.5 Components and Cardiovascular Diseases: A Cohort Study of 0.5 Million Chinese Adults. J Am Coll Cardiol. 2026 Jun 16. doi:10.1016/j.jacc.2026.04.006. PMID: 42340288.
Brook RD, Rajagopalan S, Pope CA 3rd, et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010 Jun 1;121(21):2331-78. doi:10.1161/CIR.0b013e3181dbece1.
Kelly FJ, Fussell JC. Air pollution and public health: emerging hazards and improved understanding of risk. Environ Geochem Health. 2015 Aug;37(4):631-49. doi:10.1007/s10653-015-9720-1.
Pope CA 3rd, Dockery DW. Health effects of fine particulate air pollution: lines that connect. J Air Waste Manag Assoc. 2006 Jun;56(6):709-42.
Shah ASV, Langrish JP, Nair H, et al. Global association of air pollution and heart failure: a systematic review and meta-analysis. Lancet. 2013 Feb 9;382(9897):1039-48.